Cargando…

Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells

The mechanism of resistance to 5‐fluorouracil (5‐FU) was studied with NUGC‐3/5FU/L, a human stomach cancer cell line which had acquired resistance as a consequence of repeated 5‐day exposures to stepwise‐increasing concentrations of 5‐FU in vitro. NUGC‐3/5FU/L was 200‐fold and over 16‐fold resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inaba, Makoto, Mitsuhashi, Junko, Sawada, Hiroko, Miike, Naoko, Naoe, Yoshinori, Daimon, Aiko, Koizumi, Kazuhisa, Tsujimoto, Hiroaki, Fukushima, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921054/ https://www.ncbi.nlm.nih.gov/pubmed/8609072 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03161.x

Ejemplares similares

Circumvention of 5‐Fluorouracil Resistance in Human Stomach Cancer Cells by Uracil Phosphoribosyltransferase Gene Transduction
por: Inaba, Makoto, et al.
Publicado: (1999)

Screening of Differentially Expressed Genes in 5‐Fluorouracil‐resistant Human Gastrointestinal Tumor Cells
por: Takechi, Teiji, et al.
Publicado: (2001)

Kinetic Analysis of 5‐Fluorouracil Action against Various Cancer Cells
por: Inaba, Makoto, et al.
Publicado: (1990)

Increased Sensitivity to Long‐term 5‐Fluorouracil Exposure of Human Colon Cancer HT‐29 Cells Resistant to Short‐term Exposure
por: Inaba, Makoto, et al.
Publicado: (1998)

Pharmacokinetic Modulation of Plasma 5‐Fluorouracil Concentrations to Potentiate the Antitumor Activity of Continuous Venous Infusion of 5‐Fluorouracil
por: Fujii, Setsuro, et al.
Publicado: (1989)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
por: Machon, Christelle, et al.
Publicado: (2021)

Different Modes of Cell‐killing Action between DNA Topoisomerase I and II Inhibitors Revealed by Kinetic Analysis
por: Inaba, Makoto, et al.
Publicado: (1994)

Antitumor Activity of BOF‐A2, a New 5‐Fluorouracil Derivative
por: Fujii, Setsuro, et al.
Publicado: (1989)

Anabolic Therapies
por: Lane, Nancy E., et al.
Publicado: (2010)

Building Body With Anabolics Is Weakening the Heart: Anabolic Steroid Induced Cardiomyopathy
por: Bhattad, Pradnya Brijmohan, et al.
Publicado: (2022)

Anabolic‐androgenic anabolic steroids as a probable risk factor for hepatoblastoma in infants
por: Malekiantaghi, Armen, et al.
Publicado: (2023)

Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma
por: Cao, Jing-Zhu, et al.
Publicado: (2022)

Dynamic Modulation of Thymidylate Synthase Gene Expression and Fluorouracil Sensitivity in Human Colorectal Cancer Cells
por: Wakasa, Kentaro, et al.
Publicado: (2015)

Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5‐Fluorouracil
por: Ishikawa, Yoichiro, et al.
Publicado: (2000)

Newer anabolic therapies in osteopororsis
por: Mittal, Monika, et al.
Publicado: (2012)

TAp73 promotes anabolism
por: Amelio, Ivano, et al.
Publicado: (2014)

Anabolic Steroid-induced Mania
por: Franey, Daniel G, et al.
Publicado: (2018)

Postoperative diaphragmatic hernia with upside-down stomach: a case report
por: Wakabayashi, Masakazu, et al.
Publicado: (2022)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals.
por: Hagiwara, A., et al.
Publicado: (1996)

Muscle Wasting and Resistance of Muscle Anabolism: The “Anabolic Threshold Concept” for Adapted Nutritional Strategies during Sarcopenia
por: Dardevet, Dominique, et al.
Publicado: (2012)

Synchronous Double Malignant Tumors Consisting of Stomach and Hodgkin's Lymphoma with Collision between Gastric Adenocarcinoma and Hodgkin's Lymphoma in the Stomach
por: Yanagawa, Naoki, et al.
Publicado: (2012)

How It Was. Anabolic Action of Steroids and Remembrances
por: Mott, John W.
Publicado: (1987)

The Use of Anabolic Agents in Catabolic States
por: Demling, Robert
Publicado: (2007)

On the Free Energy That Drove Primordial Anabolism
por: Kaufmann, Michael
Publicado: (2009)

A review of anabolic therapies for osteoporosis
por: Lane, Nancy E, et al.
Publicado: (2003)

Mechanisms of bone anabolism regulated by statins
por: Ruan, Feng, et al.
Publicado: (2012)

Anabolic steroids abuse and male infertility
por: El Osta, Rabih, et al.
Publicado: (2016)

An inside perspective on anabolic steroid abuse
por: Schaive, Chad, et al.
Publicado: (2016)

Anabolic Therapies in Osteoporosis and Bone Regeneration
por: Russow, Gabriele, et al.
Publicado: (2018)

Glycolytic reliance promotes anabolism in photoreceptors
por: Chinchore, Yashodhan, et al.
Publicado: (2017)

Anabolic Steroids and Cardiovascular Outcomes: The Controversy
por: Perry, Jamal C, et al.
Publicado: (2020)

Anabolic-androgenic steroids and cardiovascular risk
por: Liu, Jian-Di, et al.
Publicado: (2019)

Anabolic-Androgenic Steroids and Cardiometabolic Derangements
por: Farzam, Khashayar
Publicado: (2021)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

Anabolic androgenic steroids and cardiomyopathy: an update
por: Fadah, Kahtan, et al.
Publicado: (2023)

How should tracers be injected to detect for sentinel nodes in gastric cancer – submucosally from inside or subserosally from outside of the stomach?
por: Yaguchi, Yoshihisa, et al.
Publicado: (2008)

Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
por: Nakamura, Ayako, et al.
Publicado: (2013)

Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin
por: MINEGAKI, TETSUYA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a7t9186gi3o9qd179mc0q6pnem